Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 11349 | Registry Identifier | DAIDS-ES |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether a high-quality protein food supplement will help HIV-positive patients maintain, and possibly gain, muscle mass.
Many HIV-positive patients lose weight that they are then unable to regain. This may be because patients are not eating enough protein or are not eating the right kinds of protein. The protein eaten in foods (such as meat, eggs, or beans) may not be able to make up for the amount of protein lost due to HIV infection. This study gives patients high-quality protein food supplements to help them maintain and/or gain weight.
In many HIV-infected individuals with prior weight loss, the failure to regain weight and lean tissue is at least in part the consequence of inadequate protein intake or ingestion of a poor-quality protein rather than total caloric intake. Dietary sources of protein are presumably inadequate to meet the high metabolic needs caused by HIV infection. To achieve a target protein intake in the range (1.5 to 2.0 g/kg/day) demonstrated in other catabolic diseases necessary to achieve positive nitrogen balance and to generate substantial anabolic effects, this study will administer a supplement containing high-quality protein.
Two groups of 28 patients each are randomly chosen to receive either an oral nutritional supplement (Optimune) containing increased amounts of high-quality protein (whey), which is rich in cysteine and glutamine, or an isocaloric, identical-tasting supplement without added whey protein or amino acid supplementation. Weight, body composition, anthropometry, dietary intake, and general physical health are assessed at baseline and at Weeks 6 and 12. Plasma cysteine, glutathione, C-reactive protein, and prealbumin, along with urine IL-6, sTNFrII, and IL-1ra, are assessed at baseline and at Week 12.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Optimune oral nutritional supplement | Drug |
Inclusion Criteria
You may be eligible for this study if you:
Exclusion Criteria
You will not be eligible for this study if you:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kathleen Mulligan, MD | Study Chair | |
| Bruce R. Bistrian, MD | Study Chair | |
| Fred R. Sattler, MD | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Univ of Southern California / LA County USC Med Ctr | Los Angeles | California | 900331079 | United States | ||
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UCLA CARE Ctr |
| Los Angeles |
| California |
| 90095 |
| United States |
| San Francisco Gen Hosp | San Francisco | California | 941102859 | United States |
| Stanford Univ Med Ctr | Stanford | California | 943055107 | United States |
| Univ of Colorado Health Sciences Ctr | Denver | Colorado | 80262 | United States |
| Queens Med Ctr | Honolulu | Hawaii | 96816 | United States |
| Univ of Hawaii | Honolulu | Hawaii | 96816 | United States |
| Tulane Univ School of Medicine | New Orleans | Louisiana | 70112 | United States |
| Johns Hopkins Hosp | Baltimore | Maryland | 21287 | United States |
| St Louis Regional Hosp / St Louis Regional Med Ctr | St Louis | Missouri | 63112 | United States |
| Chelsea Ctr | New York | New York | 10021 | United States |
| Cornell Univ Med Ctr | New York | New York | 10021 | United States |
| Univ of Rochester Medical Center | Rochester | New York | 14642 | United States |
| Univ of Cincinnati | Cincinnati | Ohio | 452670405 | United States |
| Ohio State Univ Hosp Clinic | Columbus | Ohio | 432101228 | United States |
| Philadelphia Veterans Administration Med Ctr | Philadelphia | Pennsylvania | 19104 | United States |
| Julio Arroyo | West Columbia | South Carolina | 29169 | United States |
| Univ of Washington | Seattle | Washington | 98104 | United States |
| Univ of Puerto Rico | San Juan | 009365067 | Puerto Rico |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D019247 | HIV Wasting Syndrome |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D019282 | Wasting Syndrome |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D009748 | Nutrition Disorders |
Not provided
Not provided